FDA Places Import Alert on Dr. Reddy’s Mexican Site

摘要

The FDA has placed an import alert on Indian pharma giant Dr. Reddy’s Mexico facility after issuing the company a warning letter last month for current good manufacturing practice (cGMP) violations.